Skip to main content Skip to section navigation Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
May 19, 2022 7:00am EDT

Societal to Participate in Upcoming Investor Conferences

May 17, 2022 7:00am EDT

Societal CDMO Unveils “20/80 Second Source Technical Transfer” Service Model, Offering Cost and Time Savings for Pharmaceutical Manufacturing

May 11, 2022 4:05pm EDT

Societal CDMO Reports First Quarter 2022 Financial Results

May 05, 2022 7:00am EDT

Societal CDMO Signs Three-Year Manufacturing and Supply Agreement With InfectoPharm for Ritalin LA® in Europe

May 04, 2022 4:05pm EDT

Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022

Apr 27, 2022 7:00am EDT

Societal CDMO Secures Manufacturing and Packaging Task Order Award from National Cancer Institute (NCI)

Apr 06, 2022 4:05pm EDT

Societal CDMO Reports Inducement Grants for New Staff

Mar 21, 2022 7:00am EDT

Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation

Mar 01, 2022 4:05pm EST

Recro Reports Fourth Quarter and Year End 2021 Financial Results

Feb 23, 2022 7:00am EST

Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facility

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 21
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2022 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us